Human papillomavirus vaccination and cervical screening uptake among women presenting for abortion: exploring opportunities for health care interventions
A significant proportion of those individuals who present for abortion are not vaccinated against HPV or up to date with cervical screening. Three-quarters of this group made an in-person visit, indicating an opportunity for delivering cervical cancer preventative services in the future. Future research is required to determine the feasibility of HPV vaccination and cervical screening in this setting.
Authors
- Sharon Cameron (ORCID: https://orcid.org/0000-0002-1168-2276)
- Gina Bonar (ORCID: https://orcid.org/0009-0002-1571-1158)
Institutions
- NHS Lothian (GB)
- University of Strathclyde (GB)
- MRC Centre for Regenerative Medicine (GB)
- MRC Centre for Reproductive Health (GB)
Publication Details
- Journal
- BMJ Sexual & Reproductive Health
- Published
- 2025-11-12
- DOI
- https://doi.org/10.1136/bmjsrh-2025-203018
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00